Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno
Danielle Brazel,1 Sai-Hong Ignatius Ou,1,2 Misako Nagasaka1– 3 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA; 3St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Misako N...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-01-01
|
| Series: | Lung Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/tiragolumab-anti-tigit-in-sclc-skyscraper-02-a-towering-inferno-peer-reviewed-fulltext-article-LCTT |